4.2 Review

Why are somatic diseases in bipolar disorder insufficiently treated?

Journal

Publisher

SPRINGEROPEN
DOI: 10.1186/s40345-019-0147-y

Keywords

Bipolar disorder; Mortality; Morbidity; Somatic illness

Categories

Ask authors/readers for more resources

BackgroundSomatic diseases, including cardiovascular, respiratory, and cancer diseases, are the main contributors to a shortened life expectancy of 10-20years in patients with bipolar disorder as compared to the general population. In the general population an increase in survival has been observed over the last decades, primarily due to the advances in primary prophylaxis, medical treatment and progress in early detection and monitoring of somatic diseases. In this narrative review, we discuss the existing literature on treatment and outcomes of cardiovascular, respiratory, and cancer diseases in patients with bipolar disorder, and put this in the context of findings in studies on patients diagnosed with other severe mental disorders.Main bodyThe existing literature suggests that patients with bipolar disorder receive fewer or delayed medical interventions, when admitted with severe somatic diseases, compared to those not diagnosed with bipolar disorder. Cardiovascular disease is the most investigated disease regarding outcomes in patients with severe mental illness, and novel findings indicate that the increased mortality following cardiac events in these patients can be reduced if they are intensively treated with secondary prophylactic cardiac intervention. Elderly patients diagnosed with mental disorders and cancer experience a delay in receiving specific cancer treatment. No studies have investigated treatment outcomes in patients with severe mental disease and respiratory diseases.ConclusionIt is surprising and of major concern that patients with bipolar disorder have not benefitted from the significant improvement that has taken place over time over time of somatic treatments in general, especially in countries with equal and free access to healthcare services. Therefore, no matter whether this situation is a result of a negative attitude from health care providers to patients with mental illness, the result of the patient's lack of awareness of their physical illness or the results of other factors, further attention including research on developing strategies for improving the management of somatic diseases in patients with bipolar disorder is needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Clinical Neurology

Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

Eva Z. Reininghaus, Mirko Manchia, Nina Dalkner, Nina Bonkat, Alessio Squassina, Isabel Hodl, Eduard Vieta, Andreas Reif, Tomas Hajek, Mikael Landen, Christoph U. Correll, Jan Scott, Bruno Etain, Marcella Rietschel, Veerle Bergink, Monica Martinez-Cengotitabengoa, Lars Vedel Kessing, Andrea Fagiolini, Michael Bauer, Guy Goodwin, Ana Gonzalez-Pinto, Ralph W. Kupka, Thomas G. Schulze, Trine Lagerberg, Aysegul Yildiz, Chantal Henry, Gunnar Morken, Phillip Ritter, Rene Ernst Nieslen, Rasmus W. Licht, Andreas Bechdolf, Ole A. Andreassen, Frederike Tabea Fellendorf

Summary: Patients with bipolar disorder may have a higher risk of contracting COVID-19, leading to worsened clinical outcomes. However, research on vaccination in individuals with BD is limited and lacks substantial evidence.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Review Psychiatry

Treatment of difficult-to-treat depression - clinical guideline for selected interventions

Stine Bjerrum Moeller, Krzysztof Gbyl, Carsten Hjorthoj, Maike Andreasen, Stephen F. Austin, Poul Erik Buchholtz, Line Fonss, Simon Hjerrild, Lise Hogervorst, Martin Balslev Jorgensen, Nicolai Ladegaard, Klaus Martiny, Jonas Meile, Aake Packness, Karen Rodriguez Sigaard, Krista Straarup, Sune P. Straszek, Claus Havregaard Soerensen, Birgitte Welcher, Poul Videbech

Summary: The study formulated an evidence-based guideline for difficult-to-treat depression in Denmark, finding weak evidence to support repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP) as interventions, but insufficient evidence for other interventions such as intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation.

NORDIC JOURNAL OF PSYCHIATRY (2022)

Article Clinical Neurology

Bipolar disorder and regretted behavior in relation to use of social media and online dating

Klara F. K. Rydahl, Rene B. K. Brund, Clara R. Medici, Krista M. N. Straarup, Sune P. Straszek, Soren D. Ostergaard

Summary: Individuals with bipolar disorder are more likely to engage in risk-taking behavior and subsequently regret it when using social media and online dating, compared to controls. Therefore, cautious use of these platforms is particularly important for individuals with bipolar disorder.

BIPOLAR DISORDERS (2022)

Article Psychology, Experimental

Validation of the Affect Integration Inventory in a sample of patients with personality disorders: A cross-sectional study

Christina Frederiksen, Ole Andre Solbakken, Rasmus W. Licht, Ann-Eva Christensen, Carsten Rene Jorgensen, Gry Kjaersdam Telleus

Summary: This study aimed to investigate the psychometric properties of the Affect Integration Inventory in patients with personality disorders. The results showed that the questionnaire had satisfactory internal consistency, consistent factor structure, and reliable convergent and discriminant validity.

ACTA PSYCHOLOGICA (2022)

Article Clinical Neurology

Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs

Miriam von Mucke Similon, Cecilia Paasche, Fas Krol, Bernard Lerer, Guy M. Goodwin, Michael Berk, Andreas Meyer-Lindenberg, Terence A. Ketter, Lakshmi N. Yatham, Joseph F. Goldberg, Gin S. Malhi, Rif El-Mallakh, Rasmus W. Licht, Allan H. Young, Flavio Kapczinski, Marnina Swartz, Michal Hagin, Carla Torrent, Alessandro Serretti, Aysegul Yildiz, Anabel Martinez-Aran, Sergio Strejilevich, Janusz Rybakowski, Gabriele Sani, Heinz Grunze, Gustavo Vazquez, Ana Gonzales Pinto, Jean Michel Azorin, Willem Nolen, Othman Sentissi, Carlos Lopez-Jaramillo, Benicio N. Frey, Andrew Nierenberg, Gordon Parker, David J. Bond, Adam Cohen, Alfonso Tortorella, Giulio Perugi, Eduard Vieta, Dina Popovic

Summary: This study provides consensus recommendations for the selection of clinical trial design in psychiatry by surveying clinical and academic experts. The expert panel achieved consensus on 7 out of 21 recommendations regarding the use of randomized clinical trials, strongly supporting their use.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Article Psychiatry

Time trends of coronary procedures, guideline-based drugs and all-cause mortality following acute coronary syndrome in patients with bipolar disorder

Line Philipsen, Nanna Wurtz, Christoffer Polcwiartek, Kristian Hay Kragholm, Christian Torp-Pedersen, Rene Ernst Nielsen, Svend Eggert Jensen, Rubina Attar

Summary: This study analyzed the time trends in coronary procedures, guideline-based drugs, and mortality following acute coronary syndrome (ACS) in patients with and without bipolar disorder (BD). The results showed that patients with BD and ACS received fewer coronary angiography and redeemed fewer prescriptions of guideline-based drugs compared to the control group. The treatment gap remained unchanged for PCI and CABG, and the mortality risk ratio for patients with BD experiencing ACS remained constant over the study period.

NORDIC JOURNAL OF PSYCHIATRY (2023)

Article Psychiatry

Characteristics prior to and at time of diagnosis in pediatric bipolar disorder

Mathilde Frahm Laursen, Christoph U. Correll, Rasmus W. Licht, Maria Rodrigo-Domingo, Anne Katrine Pagsberg, Rene Ernst Nielsen

Summary: This study aims to describe the symptoms before and at the time of register-diagnosis in children and adolescents. A random sample from a Danish nationwide cohort of patients was selected for chart-review. The results showed that frequently reported symptoms before diagnosis include anhedonia, irritability, hyperactivity, decreased energy, and psychotic symptoms. In addition, symptoms of ADHD, anxiety, suicide attempts, cutting, and criminal activity were also reported before incident BD diagnosis.

NORDIC JOURNAL OF PSYCHIATRY (2023)

Article Psychiatry

Association between polarity of first episode and solar insolation in bipolar I disorder

Michael Bauer, Tasha Glenn, Eric D. Achtyes, Martin Alda, Esen Agaoglu, Kursat Altinbas, Ole A. Andreassen, Elias Angelopoulos, Raffaella Ardau, Memduha Aydin, Yavuz Ayhan, Christopher Baethge, Rita Bauer, Bernhard T. Baune, Ceylan Balaban, Claudia Becerra-Palars, Aniruddh P. Behere, Prakash B. Behere, Habte Belete, Tilahun Belete, Gabriel Okawa Belizario, Frank Bellivier, Robert H. Belmaker, Francesco Benedetti, Michael Berk, Yuly Bersudsky, Sule Bicakci, Harriet Birabwa-Oketcho, Thomas D. Bjella, Conan Brady, Jorge Cabrera, Marco Cappucciati, Angela Marianne Paredes Castro, Wei-Ling Chen, Eric Y. W. Cheung, Silvia Chiesa, Marie Crowe, Alessandro Cuomo, Sara Dallaspezia, Maria Del Zompo, Pratikkumar Desai, Seetal Dodd, Bruno Etain, Andrea Fagiolini, Frederike T. Fellendorf, Ewa Ferensztajn-Rochowiak, Jess G. Fiedorowicz, Kostas N. Fountoulakis, Mark A. Frye, Pierre A. Geoffroy, Ana Gonzalez-Pinto, John F. Gottlieb, Paul Grof, Bartholomeus C. M. Haarman, Hirohiko Harima, Mathias Hasse-Sousa, Chantal Henry, Lone Hoffding, Josselin Houenou, Massimiliano Imbesi, Erkki T. Isometsa, Maja Ivkovic, Sven Janno, Simon Johnsen, Flavio Kapczinski, Gregory N. Karakatsoulis, Mathias Kardell, Lars Vedel Kessing, Seong Jae Kim, Barbara Koenig, Timur L. Kot, Michael Koval, Mauricio Kunz, Beny Lafer, Mikael Landen, Erik R. Larsen, Melanie Lenger, Ute Lewitzka, Rasmus W. Licht, Carlos Lopez-Jaramillo, Alan MacKenzie, Helle Ostergaard Madsen, Simone Alberte Kongstad A. Madsen, Jayant Mahadevan, Agustine Mahardika, Mirko Manchia, Wendy Marsh, Monica Martinez-Cengotitabengoa, Klaus Martiny, Yuki Mashima, Declan M. McLoughlin, Ybe Meesters, Ingrid Melle, Fatima Meza-Urzua, Yee Ming Mok, Scott Monteith, Muthukumaran Moorthy, Gunnar Morken, Enrica Mosca, Anton A. Mozzhegorov, Rodrigo Munoz, Starlin Mythri, Fethi Nacef, Ravi K. Nadella, Takako Nakanotani, Rene Ernst Nielsen, Claire O'Donovan, Adel Omrani, Yamima Osher, Uta Ouali, Maja Pantovic-Stefanovic, Pornjira Pariwatcharakul, Joanne Petite, Andrea Pfennig, Yolanda Pica Ruiz, Marco Pinna, Maurizio Pompili, Richard Porter, Danilo Quiroz, Francisco Diego Rabelo-da-Ponte, Raj Ramesar, Natalie Rasgon, Woraphat Ratta-apha, Michaela Ratzenhofer, Maria Redahan, M. S. Reddy, Andreas Reif, Eva Z. Reininghaus, Jenny Gringer Richards, Philipp Ritter, Janusz K. Rybakowski, Leela Sathyaputri, Angela M. Scippa, Christian Simhandl, Daniel Smith, Jose Smith, Paul W. Stackhouse, Dan J. Stein, Kellen Stilwell, Sergio Strejilevich, Kuan-Pin Su, Mythily Subramaniam, Ahmad Hatim Sulaiman, Kirsi Suominen, Andi J. Tanra, Yoshitaka Tatebayashi, Wen Lin Teh, Leonardo Tondo, Carla Torrent, Daniel Tuinstra, Takahito Uchida, Arne E. Vaaler, Eduard Vieta, Biju Viswanath, Maria Yoldi-Negrete, Oguz Kaan Yalcinkaya, Allan H. Young, Yosra Zgueb, Peter C. Whybrow

Summary: This study investigated the relationship between solar insolation and the polarity of the first episode of BD I. The results showed that the greater the change in solar insolation throughout the year, the more likely the first episode polarity was depression. Other associated variables included being female and increasing percentage of gross domestic product spent on country health expenditures. This study highlights the need for increased awareness and research into circadian dysfunction throughout the course of BD.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2022)

Article Medicine, General & Internal

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Peter C. Arden, Annie Baker, James C. Bennett, Catherine Bird, Renske E. Blom, Christine Brennan, Donna Brusch, Lisa Burke, Kete Campbell-Coker, Robin Carhart-Harris, Joseph Cattell, Aster Daniel, Charles DeBattista, Boadie W. Dunlop, Katherine Eisen, David Feifel, MacKenzie Forbes, Hannah M. Haumann, David J. Hellerstein, Astrid I. Hoppe, Muhammad I. Husain, Luke A. Jelen, Jeanine Kamphuis, Julie Kawasaki, John R. Kelly, Richard E. Key, Ronit Kishon, Stephanie Knatz Peck, Gemma Knight, Martijn H. B. Koolen, Melanie Lean, Rasmus W. Licht, Jessica L. Maples-Keller, Jan Mars, Lindsey Marwood, Martin C. McElhiney, Tammy L. Miller, Arvin Mirow, Sunil Mistry, Tanja Mletzko-Crowe, Liam N. Modlin, Rene E. Nielsen, Elizabeth M. Nielson, Sjoerd R. Offerhaus, Veronica O'Keane, Tomas Palenicek, David Printz, Marleen C. Rademaker, Aumer van Reemst, Frederick Reinholdt, Dimitris Repantis, James Rucker, Samuel Rudow, Simon Ruffell, A. John Rush, Robert A. Schoevers, Mathieu Seynaeve, Samantha Shao, Jair C. Soares, Metten Somers, Susan C. Stansfield, Diane Sterling, Aaron Strockis, Joyce Tsai, Lucy Visser, Mourad Wahba, Samuel Williams, Allan H. Young, Paula Ywema, Sidney Zisook, Ekaterina Malievskaia

Summary: Psilocybin may be effective in treating treatment-resistant depression, but dosage and adverse effects need further investigation.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Clinical Neurology

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James C. Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly R. Lennard-Jones, Rasmus W. Licht, Lindsey Marwood, Sunil Mistry, Tomas Palenicek, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie J. Simmons, Jair C. Soares, Metten Somers, Susan C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia

Summary: This study explores the efficacy of COMP360, a synthetic formulation of psilocybin, in treating treatment-resistant depression (TRD). Results show that a single dose of psilocybin at 25 mg and 10 mg can significantly improve symptoms of depression. This study expands on previous research on the use of psilocybin in treating TRD.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Article Psychiatry

Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder

Michael Bauer, Tasha Glenn, Eric D. Achtyes, Martin Alda, Esen Agaoglu, Kuersat Altinbas, Ole A. Andreassen, Elias Angelopoulos, Raffaella Ardau, Memduha Aydin, Yavuz Ayhan, Christopher Baethge, Rita Bauer, Bernhard T. Baune, Ceylan Balaban, Claudia Becerra-Palars, Aniruddh P. Behere, Prakash B. Behere, Habte Belete, Tilahun Belete, Gabriel Okawa Belizario, Frank Bellivier, Robert H. Belmaker, Francesco Benedetti, Michael Berk, Yuly Bersudsky, Sule Bicakci, Harriet Birabwa-Oketcho, Thomas D. Bjella, Conan Brady, Jorge Cabrera, Marco Cappucciati, Angela Marianne Paredes Castro, Wei-Ling Chen, Eric Y. W. Cheung, Silvia Chiesa, Marie Crowe, Alessandro Cuomo, Sara Dallaspezia, Maria Del Zompo, Pratikkumar Desai, Seetal Dodd, Bruno Etain, Andrea Fagiolini, Frederike T. Fellendorf, Ewa Ferensztajn-Rochowiak, Jess G. Fiedorowicz, Kostas N. Fountoulakis, Mark A. Frye, Pierre A. Geoffroy, Michael J. Gitlin, Ana. Gonzalez-Pinto, John F. Gottlieb, Paul Grof, Bartholomeus C. M. Haarman, Hirohiko Harima, Mathias Hasse-Sousa, Chantal Henry, Lone Hoffding, Josselin Houenou, Massimiliano Imbesi, Erkki T. Isometsa, Maja Ivkovic, Sven Janno, Simon Johnsen, Flavio Kapczinski, Gregory N. Karakatsoulis, Mathias Kardell, Lars Vedel Kessing, Seong Jae Kim, Barbara Koenig, Timur L. Kot, Michael Koval, Mauricio Kunz, Beny Lafer, Mikael Landen, Erik R. Larsen, Melanie Lenger, Rasmus W. Licht, Carlos Lopez-Jaramillo, Alan MacKenzie, Helle Ostergaard Madsen, Simone Alberte Kongstad A. Madsen, Jayant Mahadevan, Agustine Mahardika, Mirko Manchia, Wendy Marsh, Monica Martinez-Cengotitabengoa, Julia Martini, Klaus Martiny, Yuki Mashima, Declan M. McLoughlin, Ybe Meesters, Ingrid Melle, Fatima Meza-Urzua, Pavol Mikolas, Yee Ming Mok, Scott Monteith, Muthukumaran Moorthy, Gunnar Morken, Enrica Mosca, Anton A. Mozzhegorov, Rodrigo Munoz, Starlin V. Mythri, Fethi Nacef, Ravi K. Nadella, Takako Nakanotani, Rene Ernst Nielsen, Claire O'Donovan, Adel Omrani, Yamima Osher, Uta Ouali, Maja Pantovic-Stefanovic, Pornjira Pariwatcharakul, Joanne Petite, Johannes Petzold, Andrea Pfennig, Yolanda Pica Ruiz, Marco Pinna, Maurizio Pompili, Richard J. Porter, Danilo Quiroz, Francisco Diego Rabelo-da-Ponte, Raj Ramesar, Natalie Rasgon, Woraphat Ratta-apha, Michaela Ratzenhofer, Maria Redahan, M. S. Reddy, Andreas Reif, Eva Z. Reininghaus, Jenny Gringer Richards, Philipp Ritter, Janusz K. Rybakowski, Leela Sathyaputri, Angela M. Scippa, Christian Simhandl, Daniel Smith, Jose Smith, Jr Paul W. Stackhouse, Dan J. Stein, Kellen Stilwell, Sergio Strejilevich, Kuan-Pin Su, Mythily Subramaniam, Ahmad Hatim Sulaiman, Kirsi Suominen, Andi J. Tanra, Yoshitaka Tatebayashi, Wen Lin Teh, Leonardo Tondo, Carla Torrent, Daniel Tuinstra, Takahito Uchida, Arne E. Vaaler, Eduard Vieta, Biju Viswanath, Maria Yoldi-Negrete, Oguz Kaan Yalcinkaya, Allan H. Young, Yosra Zgueb, Peter C. Whybrow

Summary: This exploratory study investigated the association between the age of onset of bipolar I disorder and the threshold for UVB sufficient for vitamin D production. The results showed that the age of onset at locations with UVB threshold below the threshold was 1.66 years younger than those with UVB threshold equal to or above the threshold. The conclusion suggests that UVB and vitamin D may play an important role in the development of bipolar disorder.

INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2023)

Editorial Material Psychiatry

The true effect of lithium is hard to determine

Rene Ernst Nielsen, Rasmus W. Licht

Summary: Lithium is the primary choice for preventing bipolar disorder relapses, with data supporting its effectiveness in managing symptoms and preventing relapse.

BJPSYCH OPEN (2023)

Article Pediatrics

Treatment Provided in Children and Adolescents with Functional Seizures-A Danish Nationwide Cohort

Nana Brandborg Sorensen, Rene Ernst Nielsen, Ann-Eva Christensen, Mikkel Kristian Kjeldsen, Charlotte Ulrikka Rask, Jakob Christensen, Anne Sofie Hansen

Summary: This study examined the treatment and collaboration among 334 Danish children and adolescents diagnosed with functional seizures. The most commonly used treatment modalities were psychoeducation and outpatient follow-up. Only a few patients received the recommended combination of psychoeducation, outpatient follow-up, and psychotherapy. Implementing a multidisciplinary treatment approach should be explored to improve the treatment for this group.

CHILDREN-BASEL (2023)

No Data Available